Anti-GD2 Monoclonal Antibody1vial

2-Iodo-3-methyl-5-(trifluoromethyl)phenol, 98%, 5g

Octadecylsuccinic anhydride, 95.0%, 25g

(1H-Pyrrolo[2,3-b]pyridin-4-yl)boronic acid, 95.0%, 250mg

4-amino-2H-3,1-benzothiazine-2-thione, 98%, 100mg

3-(Triethoxysilyl)propyl 2-Bromo-2-methylpropanoate>93.0%(GC)1g

5,6-Dimethylbenzo[d]thiazol-2-amine, 95.0%, 250mg

1-(3-Chlorophenyl)-2,2,2-trifluoroethanol, 95.0%, 1g

[1-(1-adamantyl)-1-methylethyl]amine hydrochloride, 95.0%, 1g

2,4,6-Trimethylphenol, 95.0%, 100g

2-Isopropoxy-4,4,6-trimethyl-1,3,2-dioxaborinane, 95+%, 25g

tert-Butyl ((2-aminopyridin-4-yl)methyl)carbamate, 95.0%, 250mg

(2E)-1-(4-ethylphenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 10g